Pliant Therapeutics Stock In The News
| PLRX Stock | USD 1.54 0.02 1.32% |
Our overall analysis of Pliant Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Pliant Therapeutics. The specific impact of Pliant Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Pliant Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Pliant Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Pliant Therapeutics Backtesting and Pliant Therapeutics Hype Analysis. For more information on how to buy Pliant Stock please use our How to Invest in Pliant Therapeutics guide.
Pliant |
Pliant Therapeutics Today Top News and Investor Outlook
Pliant Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Pliant and other traded companies coverage with news coverage. We help investors stay connected with Pliant headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Pliant Stock performance. Please note that trading solely based on the Pliant Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Pliant Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Pliant earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Pliant Therapeutics that are available to investors today. That information is available publicly through Pliant media outlets and privately through word of mouth or via Pliant internal channels. However, regardless of the origin, that massive amount of Pliant data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pliant Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pliant Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pliant Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pliant Therapeutics alpha.
Pliant Largest EPS Surprises
Earnings surprises can significantly impact Pliant Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-02-28 | 2021-12-31 | -0.76 | -0.68 | 0.08 | 10 | ||
2022-11-08 | 2022-09-30 | -0.74 | -0.65 | 0.09 | 12 | ||
2024-02-27 | 2023-12-31 | -0.81 | -0.69 | 0.12 | 14 | ||
2025-02-25 | 2024-12-31 | -0.9552 | -0.82 | 0.1352 | 14 | ||
2021-03-16 | 2020-12-31 | -0.71 | -0.54 | 0.17 | 23 | ||
2020-11-10 | 2020-09-30 | -0.85 | -0.47 | 0.38 | 44 |
Pliant Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Pliant Therapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
13th of March 2025
Drug developers Pliant and Acelyrin adopt poison pill provisions to fend off activist inve... at bizjournals.com
5th of March 2025
INVESTOR ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant The... at globenewswire.com
4th of March 2025
Pliant Therapeutics Drops IPF Drug Trial After Review, Analyst Flags Uncertain Future at benzinga.com
3rd of March 2025
Pliant Therapeutucs Shares Halted After Bexotegrast Phase 2b Trial Discontinued at marketwatch.com
26th of February 2025
Acquisition by Lefebvre Eric of 45650 shares of Pliant Therapeutics subject to Rule 16b-3 at MacroaxisInsider
13th of February 2025
Pliant Therapeutics Cut to Neutral at HC Wainwright at thelincolnianonline.com
23rd of January 2025
Acquisition by Coulie Bernard of 325000 shares of Pliant Therapeutics at 11.14 subject to ... at MacroaxisInsider
Pliant Therapeutics Investors Sentiment
The influence of Pliant Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pliant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Pliant Therapeutics' public news can be used to forecast risks associated with an investment in Pliant. The trend in average sentiment can be used to explain how an investor holding Pliant can time the market purely based on public headlines and social activities around Pliant Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pliant Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pliant Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pliant Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Pliant Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pliant Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pliant Therapeutics' short interest history, or implied volatility extrapolated from Pliant Therapeutics options trading.
Additional Tools for Pliant Stock Analysis
When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.